What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

| September 3, 2008 | 0 Comments

by Mark Lebwohl, MD Author: Dr. Mark Lebwohl, MD, is Professor and Chairman, Department of Dermatology, The Mount Sinai School of Medicine, New York, NY. Section Editor: Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and […]

Continue Reading